Relaxin-2-secreting CAR-T cells exhibit enhanced efficacy in stromal-rich xenograft tumors

IntroductionChimeric antigen receptor (CAR)-T cell therapy has demonstrated notable efficacy in treating hematological malignancies. Although it has shown promise in the clinical management of solid tumors, poor outcomes in clinical trials highlight the challenges in developing therapies suitable fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Hisataka Ogawa, Tomoya Ekawa, Yu Mizote, Takashi Akazawa, Hideaki Tahara
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1506204/full
Tags: Add Tag
No Tags, Be the first to tag this record!